EQUITY RESEARCH MEMO

Fuji Yakuhin

Generated 5/24/2026

Executive Summary

Conviction (model self-assessment)65/100

Fuji Yakuhin is a Japanese integrated pharmaceutical company with a unique business model centered on 'Hachi-yaku' (placement medicine) services. The company operates across the entire pharmaceutical value chain, from manufacturing to distribution through its own drugstores and placement sales network. Its focus is on OTC medicines, health supplements, and prescription drug distribution, serving households and medical institutions across Japan. Founded in 1930, Fuji Yakuhin has established a strong foothold in the domestic market, leveraging its direct-to-consumer placement model to capture demand in underserved regions. With over 1,000 employees, the company continues to expand its network, aiming to increase household penetration and market share in the growing OTC and self-care segment.

Upcoming Catalysts (preview)

  • Q3 2026Expansion of placement medicine network into new prefectures70% success
  • Q1 2027Launch of new OTC health supplement targeting aging population60% success
  • Q4 2026Strategic partnership with major pharmacy chain for distribution50% success
Locked sections
  • · Pipeline Analysis
  • · Competitive Landscape
  • · Catalyst Calendar (full 12-month)
  • · Bull Case
  • · Bear Case
  • · Counterfactual Scenarios
  • · Valuation Notes
  • · SEC Filing Highlights
  • · Insider Activity
  • · Literature Watch
  • · Patent Landscape
  • · Mechanism Cluster Map
  • · Audio Briefing (5 min)